-
HOOKIPA Pharma Inc. NASDAQ:HOOK HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on its proprietary arenavirus platform that reprograms the body's immune system.
Location: | Website: www.hookipapharma.com | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
-36.09M
Cash
77.15M
Avg Qtr Burn
-18.47M
Short % of Float
0.52%
Insider Ownership
21.44%
Institutional Own.
37.16%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Eseba-vec (HB-200) (TheraT® LCMV) + pembrolizumab Details Cancer, Human papillomavirus, HPV+ oropharyngeal cancer | Phase 2/3 Initiation | |
HB-400 Details Hepatitis B | Phase 2 Initiation | |
HB-202/HB-201 Details Cancer, Human papillomavirus | Phase 1/2 Data readout | |
HB-500 Details Human immunodeficiency virus | Phase 1b Data readout | |
HB-700 Details Cancer, Lung cancer, Colorectal cancer , Pancreatic cancer | Phase 1 Initiation | |
HB-101 (VaxWave®) Details Cytomegalovirus, Infectious disease, Kidney transplantation | Failed Discontinued | |
HB-300 Details Cancer, Castration-resistant prostate cancer | Failed Discontinued |